. Lyon, France) for providing PrV glycoproteins and virulent PrV and Dr F, Lefevre

. France, ) for their excellent technical assistance. This study was supported by grant QLK2-CT- 496 2002-01204, FMDnaVacc project

H. L. Bachrach, Foot-And-Mouth Disease, Annual Review of Microbiology, vol.22, issue.1, pp.201-244, 1968.
DOI : 10.1146/annurev.mi.22.100168.001221

K. C. Mccullough, Immune response characteristics following emergency 563 vaccination of pigs against foot-and-mouth disease, Vaccine, vol.23, pp.1037-1047, 2005.

S. J. Barteling and J. Vreeswijk, Developments in foot-and-mouth disease vaccines, Vaccine, vol.9, issue.2, pp.75-88, 1991.
DOI : 10.1016/0264-410X(91)90261-4

F. Bergamin, L. Saurer, V. Neuhaus, K. C. Mccullough, and A. Summerfield, Porcine B-cell activating factor promotes anti-FMDV antibodies in vitro but not in vivo after DNA vaccination of pigs, Veterinary Immunology and Immunopathology, vol.120, issue.3-4, pp.115-123, 2007.
DOI : 10.1016/j.vetimm.2007.06.021

P. Barnett and F. Sobrino, Interspecies major histocompatibility complex- 571 restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4, J. 572 Virol, vol.74, pp.4902-4907, 2000.

F. Sobrino and F. Rodriguez, DNA vaccines expressing B and T cell epitopes can 575 protect mice from FMDV infection in the absence of specific humoral responses, Vaccine, vol.24, pp.576-3889, 2006.

L. Cedillo-barron, M. Foster-cuevas, G. J. Belsham, F. Lefevre, and R. M. Parkhouse, 578 Induction of a protective response in swine vaccinated with DNA encoding foot-and- 579 mouth disease virus empty capsid proteins and the 3D RNA polymerase, J. Gen. Virol, vol.580, issue.82, pp.1713-1724, 2001.

F. Lefevre and R. M. Parkhouse, Immunogenicity of plasmids encoding T and B 583 cell epitopes of foot-and-mouth disease virus (FMDV) in swine, Vaccine, vol.21, pp.4261-584, 2003.

L. Chen and H. Shao, Extract from Agaricus blazei Murill can enhance immune responses elicited by DNA vaccine against foot-and-mouth disease, Veterinary Immunology and Immunopathology, vol.109, issue.1-2, pp.177-182, 2006.
DOI : 10.1016/j.vetimm.2005.08.028

S. J. Cox, N. Aggarwal, R. J. Statham, and P. V. Barnett, Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines, Vaccine, vol.21, issue.13-14, pp.1336-1347, 2003.
DOI : 10.1016/S0264-410X(02)00691-6

D. Dory, V. Béven, A. M. Torché, S. Bougeard, R. Cariolet et al., CpG motif in ATCGAT hexamer improves DNA-vaccine efficiency against lethal Pseudorabies virus infection in pigs, Vaccine, vol.23, issue.36, pp.4532-4540, 2005.
DOI : 10.1016/j.vaccine.2005.03.046

D. Dory, A. M. Torché, V. Béven, P. Blanchard, C. Loizel et al., Effective protection of pigs against lethal Pseudorabies virus infection after a single injection of low-dose Sindbis-derived plasmids encoding PrV gB, gC and gD glycoproteins, Vaccine, vol.23, issue.26, pp.3483-3491, 2005.
DOI : 10.1016/j.vaccine.2004.10.050

Y. Du, P. Jiang, Y. Li, H. He, W. Jiang et al., Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor, Vaccine, vol.25, issue.49, pp.8209-8219, 2007.
DOI : 10.1016/j.vaccine.2007.09.062

V. Dufour, S. Chevallier, R. Cariolet, S. Somasundaram, F. Lefèvre et al., Induction of porcine cytokine mRNA expression after DNA immunization and 603 pseudorabies virus infection, J. Interferon Cytokine Res, vol.602, issue.20, pp.885-890, 2000.

H. Fan, T. Tong, H. Chen, and A. Guo, Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus, Virus Genes, vol.72, issue.2, pp.347-357, 2007.
DOI : 10.1007/s11262-007-0105-0

F. D. Finkelman, I. M. Katona, J. F. Urban, . Jr, J. Holmes et al., IL-4 is required to generate and sustain in vivo IgE responses, J. 609 Immunol, vol.141, pp.2335-2341, 1988.

M. J. Francis, C. M. Fry, D. J. Rowlands, J. L. Bittle, R. A. Houghten et al., Immune response to uncoupled peptides of foot-and-mouth disease virus, Immunology, vol.61, pp.612-613, 1987.

R. Gravier, D. Dory, F. Rodriguez, S. Bougeard, V. Beven et al., Immune and protective abilities of ubiquitinated and non-ubiquitinated pseudorabies 615 virus glycoproteins, Acta Virol, vol.51, pp.614-649, 2007.

M. J. Grubman, Development of novel strategies to control foot-and-mouth disease: Marker vaccines and antivirals, Biologicals, vol.33, issue.4, pp.227-234, 2005.
DOI : 10.1016/j.biologicals.2005.08.009

M. J. Grubman and B. Baxt, Foot-and-Mouth Disease, Clinical Microbiology Reviews, vol.17, issue.2, pp.465-493, 2004.
DOI : 10.1128/CMR.17.2.465-493.2004

E. E. Heldwein, H. Lou, F. C. Bender, G. H. Cohen, R. J. Eisenberg et al., Crystal Structure of Glycoprotein B from Herpes Simplex Virus 1, Science, vol.313, issue.5784, pp.217-621, 2006.
DOI : 10.1126/science.1126548

G. M. Keil, C. Hohle, K. Giesow, and P. Konig, Engineering Glycoprotein B of Bovine Herpesvirus 1 To Function as Transporter for Secreted Proteins: a New Protein Expression Approach, Journal of Virology, vol.79, issue.2, pp.791-799, 2005.
DOI : 10.1128/JVI.79.2.791-799.2005

A. M. King, B. O. Underwood, D. Mccahon, J. W. Newman, and F. Brown, Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the UK, Nature, vol.71, issue.5832, pp.479-480, 1981.
DOI : 10.1038/293479a0

Y. Li, N. Aggarwal, H. H. Takamatsu, C. M. Sterling, C. Voyce et al., Enhancing immune responses against a plasmid DNA vaccine encoding a FMDV empty capsid from serotype O, Vaccine, vol.24, issue.21, pp.4602-4606, 2006.
DOI : 10.1016/j.vaccine.2005.08.032

Y. Li, C. M. Stirling, M. S. Denyer, P. Hamblin, G. Hutchings et al., Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost, Vaccine, vol.26, issue.21, pp.2647-2656, 2008.
DOI : 10.1016/j.vaccine.2008.01.037

Y. G. Li, F. L. Tian, F. S. Gao, X. S. Tang, and C. Xia, Immune responses generated by 635 Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus, Vaccine, vol.25, pp.636-902, 2007.

D. K. Mackay, A. N. Bulut, T. Rendle, F. Davidson, and N. P. Ferris, A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus, Journal of Virological Methods, vol.97, issue.1-2, pp.33-48, 2001.
DOI : 10.1016/S0166-0934(01)00333-0

H. B. Mann and D. R. Whitney, On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other, The Annals of Mathematical Statistics, vol.18, issue.1, pp.50-60, 1947.
DOI : 10.1214/aoms/1177730491

R. Nixdorf, B. G. Klupp, A. Karger, and T. C. Mettenleiter, Effects of Truncation of the Carboxy Terminus of Pseudorabies Virus Glycoprotein B on Infectivity, OIE Manual of Standards for diagnostics tests and vaccines, pp.7137-7145, 2000.
DOI : 10.1128/JVI.74.15.7137-7145.2000

M. J. Rodrigo and J. Dopazo, Evolutionary analysis of the picornavirus family, Journal of Molecular Evolution, vol.9, issue.4, pp.362-371, 1995.
DOI : 10.1007/BF00164022

M. Saiz, J. I. Nunez, M. A. Jimenez-clavero, E. Baranowski, and F. Sobrino, Foot-and-mouth disease virus: biology and prospects for disease control, Microbes and Infection, vol.4, issue.11, pp.1183-1192, 2002.
DOI : 10.1016/S1286-4579(02)01644-1

J. S. Salt, P. V. Barnett, P. Dani, and L. Williams, Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission, Vaccine, vol.16, issue.7, pp.746-754, 1998.
DOI : 10.1016/S0264-410X(97)86180-4

F. Sobrino, M. Saiz, M. A. Jimenez-clavero, J. I. Nunez, M. F. Rosas et al., Foot-and-mouth disease virus: a long known virus, but a current threat, Veterinary Research, vol.32, issue.1, pp.1-30, 2001.
DOI : 10.1051/vetres:2001106

URL : https://hal.archives-ouvertes.fr/hal-00902685

C. Stellmann, P. Vannier, G. Chappuis, A. Brun, M. Dauvergne et al., The potency testing of pseudorabies vaccines in pigs. A proposal for a quantitative criterion and a minimum requirement, Journal of Biological Standardization, vol.17, issue.1, pp.17-27, 1989.
DOI : 10.1016/0092-1157(89)90024-3

W. Boersma and A. T. Bianchi, A DNA vaccine coding for glycoprotein B of 666 pseudorabies virus induces cell-mediated immunity in pigs and reduces virus excretion 667 early after infection, Vet. Immunol. Immunopathol, vol.74, pp.121-136, 2000.

H. T. Wong, S. C. Cheng, F. W. Sin, E. W. Chan, Z. T. Sheng et al., A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2, Vaccine, vol.20, issue.21-22, pp.2641-2647, 2002.
DOI : 10.1016/S0264-410X(02)00212-8

P. R. Wood and H. F. Seow, T cell cytokines and disease prevention, Veterinary Immunology and Immunopathology, vol.54, issue.1-4, pp.33-44, 1996.
DOI : 10.1016/S0165-2427(96)05711-X

C. Xiao, H. Jin, Y. Hu, Y. Kang, J. Wang et al., Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants, Antiviral Research, vol.76, issue.1, pp.11-20, 2007.
DOI : 10.1016/j.antiviral.2007.04.002

M. M. Zaripov, O. S. Morenkov, N. Fodor, A. Brown, V. V. Schmatchenko et al., 678 Distribution of B-cell epitopes on the pseudorabies virus glycoprotein B, J. Gen. Virol, vol.679, issue.80, pp.537-541, 1999.

M. M. Zaripov, O. S. Morenkov, B. Siklodi, I. Barna-vetro, and A. Gyongyosi-horvath, Glycoprotein B of Aujeszky's disease virus: topographical epitope mapping and epitope-specific antibody response, Research in Virology, vol.149, issue.1, pp.29-41
DOI : 10.1016/S0923-2516(97)86898-7

H. Y. Zhang, S. H. Sun, Y. J. Guo, F. J. Zhou, Z. H. Chen et al., Immune response in mice inoculated with plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus, Vaccine, vol.21, issue.32, pp.4704-4707, 2003.
DOI : 10.1016/S0264-410X(03)00519-X